Location: Home
  • search
  • go
  • Relate News
  • 11/14/2022BioNTech and Fosun Pharma Receive Special Approvals for Omicron-BA.4/B...
  • 11/14/2022Snapshot of BMI System Financial Performance in 3Qs/2022
  • 11/11/2022CDE Issues the Work Procedures for Changes During Drug Registration Ap...
  • 11/11/2022NMPA Announces Package Insert Revision of Phloroglucinol Injection
  • 11/11/2022AstraZeneca Launches First Alexion Rare Disease Therapy for Patients i...
  • 11/11/2022NMPA Solicits Comments on the Special Rules for TCM Registration
  • 11/11/2022Harbour BioMed Enters into a License and Collaboration Agreement with ...
  • 11/11/2022Drug R&D and Product Registration News Digest November 2022 (2)
  • 11/11/2022Review of A Share-listed Chinese MedPharm Cos in Q3/2022
  • 11/11/2022PwC: Review of China's Pharmaceutical & Life Sciences M&A Deals in 202...
  • 11/10/2022AstraZeneca Reports Strong Quarterly Results with China Growth Despite...
  • 11/10/2022China's Biopharma Industry: Market Prospects, Investment Paths (China ...
  • 11/10/2022Under Geopolitics and Market Rout, Chinese Biotechs Center on Data Qua...
  • 11/9/2022Sanofi and Insilico Medicine Enter $1.2B Strategic Research Collaborat...
  • 11/9/2022China Issues the 14th Five-Year Plan for Universal Health Informatizat...
  • 11/9/2022Review of China's Commercial Health Insurance Sector Development 2007-...
  • 11/8/2022NMPA Solicits Comments on the Technical Guidelines for Clinical Resear...
  • 11/8/2022CDE Issues the Technical Guidelines for Alcohol Dose Dumping Tests in ...
  • 11/8/2022CDE Issues on the Q&As on Research Conditions of Dissolution Curve in ...
  • 11/8/2022CDE Solicits Comments on the Technical Guidelines for New Drug Benefit...
  • 11/8/2022HEC Barred from Selling Linagliptin Products following Patent Ruling (...
  • 11/7/2022Trends and Characteristics of New Drug Approvals in China, 2011–2021
  • 11/7/2022NMPA Solicits Comments on Documents Relating To e-Submission of Drug R...
  • 11/6/2022CBC to Build a $137 Million Biopharma Complex in Western Shanghai
  • 11/6/2022Eucure Inks Partnership with ISU ABXIS To Develop Tri-Specific Antibod...
  • 11/6/2022China to Approve BioNTech's Covid-19 Vaccine for Foreigners with Pathw...
  • 11/6/2022Germany Pharma CEOs Visit China with German Chancellor Scholz
  • 11/4/2022NMPA Announces Package Insert Revision of Methotrexate Oral Formulatio...
  • 11/4/2022Recent Executive Moves
  • 11/4/2022Drug R&D and Product Registration News Digest November 2022 (1)
  • Page:122/775 Total number of articles:23222: [First][<<] [120] [121] [122] [123] [124] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group